glp 1 cardiovascular risk reduction The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Reports The Multidisciplinary Approach to GLP-1

The FDA has approved the first oral GLP-1 for weight loss

Maximize the quantity and quality of your sleep while priming your body to accelerate the weight loss process with Night Shred

Whether you're focusing on weight loss, appetite control, or feeling better day-to-day, this visual chart gives you clear direction at a glance

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

We stand by G-Loop